Collectively, these findings establish IFN-I signaling as a key driver of ILC3 functional impairment during chronic HIV-1 infection, with targeted IFNAR inhibition showing the potential to reverse this immunopathological process. This evidence concerns the gene IFNAR1 and HIV-1 infection.